A Phase One clinical trial has provided promising results for an HIV vaccine.
International researchers say the vaccine, which is being tested in humans, helps create antibodies which can recognise the globally diverse strains of HIV, and could protect against infection.
Victoria University faculty of health associate professor Clive Aspin spoke to Māni Dunlop.
